Redeye provides an update on ChromoGenics following the company s Q1 2023 results. ChromoGenics continues to add strategic partners and the focus continues to be on sales activities and cost control.. | May 26, 2023
With effect from November 15, 2022, the unit rights in ChromoGenics AB will be
traded on First North Growth Market. Trading will continue up until and
including November 24, 2022. Instrument: Unit
ChromoGenics receives a new order for ConverLight® Dynamic of approximately SEK 1.1 million for delivery during 2022.
The order includes a delivery of dynamic glass to the town hall in Nannestad. | May 18, 2022
With effect from February 17, 2022, the unit rights in ChromoGenics AB will be traded on First North Growth Market. Trading will continue up until and including February 28, 2022. Instrument: Unit